MLS Bio
PrivateLast Round
Series A
Oct 10, 2025
Total Funding Raised
$1.35M
Company Overview
MLS Bio operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a SAFE round in October 2025.
MLS Bio is a biotechnology company that develops AI-driven drug development platforms and small-molecule therapies for oncology and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MLS Bio Comparables
Compare MLS Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noxopharm | 82% | |
| Aucentra Therapeutics | 78% | |
| Acerand Therapeutics | 78% |
For institutional investors. Book with your work email.
MLS Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 10, 2025 | ||||
| SAFE | Oct 10, 2025 | ||||
| Grant | Aug 30, 2022 |
For institutional investors. Book with your work email.
MLS Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perth Angels | SAFE |
| Melbourne Angels | SAFE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2025
$654K raised from Melbourne Angels and Perth Angels.
- Oct 10, 2025
$25M round completed.
For institutional investors. Book with your work email.
MLS Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MLS Bio's valuation, stock price, and market status.
Is MLS Bio a public or private company?
MLS Bio is a private company.
What is the current stock price of MLS Bio?
MLS Bio is a private company, so its shares have no public market price. Caplight tracks MLS Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MLS Bio worth (valuation)?
Valuation information for MLS Bio is not publicly available.
Can I buy MLS Bio stock?
MLS Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MLS Bio's last funding round?
MLS Bio's most recent funding round was Series A on October 10, 2025.
Who are the main investors in MLS Bio?
Key investors in MLS Bio include Perth Angels, Melbourne Angels.
Will MLS Bio IPO soon?
No public IPO plans have been announced for MLS Bio.
How can I track MLS Bio secondary market activity?
Caplight tracks bids, offers, and trades in MLS Bio's shares on secondary markets.